One Session Virtual Reality During Ongoing Treatment for Anxiety: Feasibility in Children and Adolescents

Launched by ACCARE · Mar 27, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the use of virtual reality (VR) to help children and adolescents aged 8 to 18 years who are dealing with anxiety disorders, such as social anxiety. The goal is to find out how young people and their therapists feel about using VR for exposure therapy—this means gradually facing fears in a safe environment. The study will look at whether participants find the VR sessions helpful or challenging, and how it might work to reduce their anxiety.

To join the trial, participants must be children or teenagers between 8 and 18 years old and have a diagnosed anxiety disorder. They cannot have severe mental health issues that could make it unsafe to participate. During the study, those who are eligible will take part in one VR session while continuing their regular treatment. It’s important to know that this trial is not yet recruiting participants, but it aims to gather valuable information that could improve anxiety treatment for young people in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Children and adolescents 8-18 years old.
• • Meeting Diagnostic and Statistical Manual of Mental Disorders -5 criteria for an anxiety disorder, based on a semi-structured interview (SCID-5 Jr, specific section) or clinical judgment of an experienced and authorized clinician.
• Exclusion Criteria:
• • Severe psychiatric symptoms other than anxiety disorder interfering with safety or warranting immediate intervention, e.g. psychosis or acute suicidality.